Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB)

CUSIP: 83422E105

Q2 2021 13F Holders as of 30 Jun 2021

Holder snapshot 7 signals
Share change
+1,053,853
Put/Call ratio
88%
SEC-reported price per share
$3.66
Number of holders
86
Value change
+$60,718
Number of buys
47
Open additional details 1 more signal available
Number of sells
47
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
100,767,588

Security key

83422E105

Report period

Q2 2021

Institutions

86

Top holders

10

Ownership snapshot

Top reported holders of SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
0/15
Latest evidence
31 Mar 2021
13F Highest disclosed value: $74,171,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $74.17M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
PERCEPTIVE ADVISORS LLC $74.17M
RA CAPITAL MANAGEMENT, L.P. $68.39M
EcoR1 Capital, LLC $50.89M
Bain Capital Life Sciences Invest... $43.85M
MONTANOVA CAPITAL, LLC $33.04M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$74,171,000
13,412,552 shares
— 31 Mar 2021
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$68,394,000
12,367,873 shares
— 31 Mar 2021
EcoR1 Capital, LLC
13F
Company
13F
—
denominator unverified
$50,891,000
9,202,702 shares
— 31 Mar 2021
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
—
denominator unverified
$43,852,000
7,929,918 shares
— 31 Mar 2021
MONTANOVA CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$33,037,000
5,974,193 shares
— 31 Mar 2021
Boxer Capital, LLC
13F
Company
13F
—
denominator unverified
$23,417,000
4,234,574 shares
— 31 Mar 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
86
Shares
80,038,410
Rows available
86
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2026 Across Filers

Q1 2026 holders
7
Q2 2021 holders
86
Holder diff
79
Investor Q1 2026 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2026 value Q2 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .